Lifeboat Foundation

Two newly discovered genes have been linked to schizophrenia while a previously known gene associated with schizophrenia risk has also been linked to autism in a massive new study.

Scientists say the findings increase our understanding of brain diseases and could lead to new treatment targets.

Continue reading “Scientists Identify New Schizophrenia Risk Genes in First-of-Its-Kind Study” »

😗

Martian soil is generally poor for growing plants, but researchers have used CRISPR to create gene-edited rice that might be able to germinate and grow despite the hostile habitat.

By Leah Crane

Continue reading “Gene-edited rice may be able to grow on Mars” »

Segregation of chromosomes in dividing cells can be disrupted if the cells are constrained by their surroundings.

One of the aberrant features of cancer cells is a failure to distribute chromosomes properly when the cells divide. Researchers have now found that a specific problem with the chromosome-distribution machinery can become more common in cancer cells confined within shallow microscopic channels—but also that, surprisingly, increasing the physical constraints can suppress these errors [1]. Such confinement mimics the effects of crowding by surrounding cells in a tumor, and the researchers believe the results might help to explain what goes awry in cancers and perhaps offer clues to how it might be put right.

In a healthy, dividing cell, after the genome is replicated, the chromosomes are segregated into two groups. Both groups are bound to the mitotic spindle, a bundle of aligned filaments (called microtubules) that are pinched together at the ends into structures called poles. The chromosomes are then drawn along the microtubules toward the poles. A key cause of improper chromosome segregation in cancer cells is the formation of spindles with more than two poles. Multipolar spindle formation inside living organisms may differ from the phenomenon when observed in cells grown in a dish [2], so it is possible that the confining effect of the surrounding cells in a tissue has some influence on this process.

Year 2022 😗😁 Basically more thought on this virus seems more like a foglet biotechnology so it would stand to reason that a nanotechnology with biotechnology could solve the universal vaccine.

Ending the covid pandemic might well require a vaccine that protects against any new strains. Researchers may have found a strategy that will work.

Year 2022 This is their published work on the universal vaccine of the covid 19.

A mosaic sarbecovirus nanoparticle protects against SARS-2 and SARS-1, whereas a SARS-2 nanoparticle only protects against SARS-2.

Drug developers are now trying to target ceramides, which appear to contribute to a range of metabolic disorders.

(NewsNation) — Studies have shown that Alzheimer’s may become the defining disease of the baby boomer generation.

According to The Alzheimer’s Association, the number of people age 65 and over living with Alzheimer’s now is nearly 7 million. That number is expected to rise to over 13 million by 2050.

Physician and best-selling author Dr. Ian Smith says it’s not known exactly what causes Alzheimer’s.

An uncultivated, aerobic chemolithotrophic Sulfurimonas species with a reduced genome is abundant across diverse, hydrogen-rich hydrothermal plumes in the deep ocean.

What if death was not the end? What if, instead of saying our final goodbyes to loved ones, we could freeze their bodies and bring them back to life once medical technology has advanced enough to cure their fatal illnesses? This is the mission of Tomorrow Biostasis, a Berlin-based startup that specializes in cryopreservation.

Cryopreservation, also known as biostasis or cryonics, is the process of preserving a human body (or brain) in a state of suspended animation, with the hope that it can be revived in the future when medical technology has advanced enough to treat the original cause of death. This may seem like science fiction, but it is a legitimate scientific procedure, and Tomorrow Biostasis is one of the few companies in the world that offers this service.

Dr Emil Kendziorra, co-founder and CEO of Tomorrow Biostasis explained that the goal of cryopreservation is to extend life by preserving the body until a cure can be found for the original illness. He emphasized that cryopreservation is not a form of immortality, but rather a way to give people a second chance at life.